Absorica vs. Claravis

• Are Absorica and Claravis the Same Thing?
• What Are Possible Side Effects of Absorica?
• What Are Possible Side Effects of Claravis?
• What Is Absorica?
• What Is Claravis?
• What Drugs Interact with Absorica?
• What Drugs Interact with Claravis?
• How Should Absorica Be Taken?
• How Should Claravis Be Taken?

Absorica (isotretinoin) and Claravis (isotretinoin capsules) are retinoids, a form of vitamin A, used to treat a severe form of acne called nodular acne.

Side effects of Absorica and Claravis that are similar include dry skin, chapped lips, eye inflammation (dry eyes, burning, redness, itching), and dry nose that may lead to nosebleeds.

Side effects of Absorica that are different from Claravis include mental health problems (such as depression, psychosis, or thoughts of suicide), fatigue, skin reactions such as infections or rash, bone or joint pain, difficulty moving, inflammation of the lips (including scaling, redness, pain, burning), and abdominal pain.

Both Absorica and Claravis may interact with vitamin supplements containing Vitamin A, tetracycline antibiotics, phenytoin, St. John's wort, systemic corticosteroids, and oral contraceptives.

Common side effects of Absorica include:

• mental health problems (such as depression, psychosis, or thoughts of suicide),
• fatigue,
• skin reactions such as infections or rash,
• dry skin,
• bone or joint pain,
• eye inflammation (dry eyes, burning, redness, itching),
• difficulty moving,
• dry nose that can lead to nosebleeds,
• inflammation of the lips (including chapping, scaling, redness, pain, burning), and
• abdominal pain

Contact your doctor immediately if you experience depression, thoughts of suicide, or psychosis while taking Absorica.

Common side effects of Claravis include:

• dry skin,
• chapped lips,
• dry eyes, and
• dry nose that may lead to nosebleeds.

Tell your doctor if you have serious side effects of Claravis including:

• increased brain pressure (severe headache, blurred vision, dizziness, nausea, vomiting, seizures, or stroke);
• a rash with a fever,
• blisters on legs, arms or face and/or
• sores in your mouth, throat, nose, eyes, or
• if your skin begins to peel;
• severe stomach, chest, or bowel pain;
• trouble swallowing or painful swallowing,
• new or worsening heartburn,
• diarrhea,
• rectal bleeding,
• yellowing of your skin or eyes,
• dark urine,
• back pain,
• joint pain,
• broken bones,
• hearing problems,
• vision problems, and
• blood sugar problems.

Absorica (isotretinoin) is a retinoid, a form of vitamin A, used to treat a severe form of acne called nodular acne in patients 12 years of age and older who have not been helped by other acne treatments, including antibiotics.

Claravis (isotretinoin capsules) is a retinoid indicated for the treatment of severe recalcitrant nodular acne.

Absorica may interact with steroids, seizure medications, or tetracycline antibiotics.

Absorica may also interact with vitamin supplements containing Vitamin A, St. John's wort, and oral contraceptives.

Claravis may interact with vitamin A, tetracycline antibiotics, hormonal contraceptives, St. John's Wort, phenytoin, and corticosteroids. Tell your doctor all medications and supplements you use. Claravis is not recommended for use during pregnancy; it may cause birth defects. Women must receive a negative pregnancy test before taking Claravis, and patients will be counseled to avoid pregnancy by using two forms of contraception simultaneously and continuously one month before, during and one month after Claravis therapy, unless the patient commits to continuous abstinence. It is unknown if Claravis passes into breast milk. Because of the potential for unwanted effects on nursing infants, breastfeeding is not recommended while using Claravis and for one month after stopping treatment.

Absorica is taken orally. The recommended dosage of 0.5 to 1 mg/kg/day is given in two divided doses for 15 to 20 weeks.

The recommended dosage range for Claravis is 0.5 to 1 mg/kg/day given in two divided doses with food for 15 to 20 weeks.